Global Health & Pharma

2019 Biotechnology Awards – WINNER

GHP Announces the 2019 Biotechnology Awards Winners

GHP Magazine has announced the winners of the 2019 Biotechnology Awards.

Most Innovative Cancer Treatment Manufacturer – Midlands

Ariane Medical Systems Ltd was delighted to be announced winners of the Most Innovative Cancer Treatment Manufacturer – Midlands regional category. Following on from our Medilink Innovation Award in June 2018 this award further shows how Papillon Brachytherapy Systems have brought new life to an old cancer treatment technique.

Read more

Ariane Macmillan Coffee Morning

Ariane Macmillan Coffee Morning

Ariane Macmillan Coffee Morning – 28th September 2018 10am to 12 noon.

Join Ariane Medical Systems as we host our Macmillan Coffee Morning on 28th September 2018.

Our coffee morning will take place between 10 am and 12 noon at Ariane Medical Systems Ltd, 151 Mansfield Road, Alfreton, DE55 7JQ.

Read more

Clatterbridge Cancer Centre win BMJ Award for Rectal Cancer Care

Clatterbridge Cancer Center win Prestigious UK Cancer Care Award

Introduction

A coveted British Medical Journal award was recently bestowed on the Papillon team at The Clatterbridge Cancer Center. The Cancer Care Team category was won by the entry—Papillon for Rectal Cancer.

This life-changing treatment was pioneered by The Clatterbridge Cancer Center when Lead Papillon Clinician Professor Arthur Sun Myint initially introduced the method to the United Kingdom, more than two decades ago. He stated that the honour was the reward for the team’s hard work and their philosophy of always putting patients’ interest first.

Read more

Ariane Medilink Innovation Award

Papillon+ receives Medilink Innovation Award

Medilink Innovation Award – Innovative Cancer Care

The award from Medilink East Midlands recognises our Papillon+ device. For its contribution to improving outcomes for rectal cancer patients.

Because Papillon+ treatments can be completed on an outpatient basis, the Papillon+ x-ray brachytherapy system can reduce treatment times. As well as preventing the need for radical surgery, which often results in a Stoma.

Read more

Papillon Patients in Phase III Opera Trial

The Phase III trial called OPERA which started in France at the end of 2015 has now passed Ethics here in the UK.

Read more

NICE ratify Papillon therapy for rectal cancer

NICE ratify X-ray brachytherapy for Rectal Cancer treatment.

The National Institute of Health & Care Excellence (NICE) have finished their consultation period for the use of Papillon X-Ray Brachytherapy for the treatment of rectal cancer and published their recommendations.

Read more

Centre Antoine-Lacassagne (Nice – France) order the first Papillon+ X-Ray Brachytherapy System

Prof Gerard, of the Centre Antoine-Lacassagne in Nice, has ordered the first Papillon+ X-Ray Brachytherapy System for the use in treating breast cancer with an IORT boost.

Read more

SCM Société Oncologie Radiotherapie (MÂCON – France) order Papillion+ X-Ray Brachytherapy System

Dr. Nicolas Barbet, of the Société Oncologie Radiotherapie in MÂCON, is the second clinician in France to place an order for the new Papillon+ X-Ray Brachy.

Read more

Clinique Generale Beaulieu (Geneva) Order Switzerland’s first Papillon+ for IORT Breast treatment

Ariane Medical Systems Ltd are very proud to announce the Clinique Generale Beaulieu, part of the Swiss Medical Network, have placed an order for the Papillon+ X-Ray Brachytherapy System for the use of delivering an IORT radiation boost for breast cancer patients.

Read more

Phase III Clinical Trial OPERA starts

The Organ Preservation of Early Rectal Adenocarcinoma (OPERA) phase III trial has started to recruit patients at the Centre Antoine-Lacassagne in Nice, France. This Pan-European trial, developed by Prof Jean-Pierre Gerard (Nice) and Prof Arthur Sun Myint (Clatterbridge, UK) is looking to recruit patients across existing Papillon users in France, UK, Sweden, Denmark and Switzerland as well as driving interest in new territories.

Read more